IWAKI (6237) FY2026 Q3 Earnings Report

Quick View

Executive Summary

The Company recorded higher revenue but lower earnings in the quarter, with the key issue being that cost absorption did not keep pace with revenue growth. Revenue was ¥34.74B (+1.8% YoY), Operating Income was ¥4.44B (△5.1%), Ordinary Income was ¥5.05B (△3.5%), and Net Income was ¥3.73B (△2.8%). The Operating Margin was 12.8%, down approximately 1pt from the same period of the previous year. Although the increased burden of SG&A expenses pressured profitability, equity-method investment income and foreign exchange gains reduced the decline at the Ordinary Income level.

Factors Affecting Results

【Revenue】Revenue was ¥34.74B, representing a 1.8% YoY increase. The Company operates as a single segment, the Chemical Pump Business, and does not disclose a segment breakdown. Progress toward the full-year plan of ¥48.44B (+5.8% YoY) was 71.7%, slightly below the standard 75% progress level.

【Profit and Loss】Operating Income was ¥4.44B (△5.1% YoY). Although the gross margin of 40.6% was maintained at approximately the previous year's level, SG&A expenses increased to ¥9.67B (SG&A ratio: 27.8%), pushing down the Operating Margin. Ordinary Income was ¥5.05B (△3.5% YoY), with non-operating income of ¥0.80B—including equity-method investment income of ¥0.52B and foreign exchange gains of ¥0.11B—offsetting part of the decline in Operating Income. Extraordinary items were limited to extraordinary income of ¥0.01B, and the impact of temporary factors was minor. Net Income was ¥3.73B (△2.8% YoY), representing higher revenue but lower earnings.

Segment Analysis

The Company operates as a single segment, the Chemical Pump Business, and does not disclose segment-level revenue or profit information.

Key Financial Indicators

【Profitability】The Operating Margin was 12.8%, down from approximately 13.7% in the same period of the previous year, while the Net Profit Margin remained high at 10.6%. Both metrics, however, deteriorated slightly YoY. 【Cash Flow Quality】Non-operating income, including interest income of ¥0.006B, equity-method investment income of ¥0.52B, and foreign exchange gains of ¥0.11B, increased Ordinary Income. The difference between Operating Income and Ordinary Income was ¥0.60B. 【Investment Efficiency】ROE was 9.5%, slightly below the 10%+ level. Total asset turnover was relatively low, against the backdrop of a conservative capital structure with an Equity Ratio of 71.7%. 【Financial Soundness】The Equity Ratio was 71.7%, and interest-bearing debt was limited, consisting primarily of long-term borrowings of ¥2.16B. Current assets of ¥36.89B versus current liabilities of ¥10.40B indicate ample liquidity.

Cash Flow Analysis

Although detailed disclosure of the statement of cash flows is unavailable, funding trends are analyzed based on changes in the balance sheet. Cash and deposits increased to ¥9.11B from ¥8.80B in the previous year, while retained earnings accumulated to approximately ¥33.95B from ¥33.66B (up YoY), indicating continued accumulation of internally generated funds through operating activities. Meanwhile, inventories remained high at ¥6.22B, suggesting that working capital, including finished goods, raw materials, and work in process, may be tying up funds. Property, plant and equipment increased to ¥9.39B, indicating that capital investment, including construction in progress, is underway. Long-term borrowings were ¥2.16B, up from ¥0.86B in the previous year, suggesting that part of the investment funding may have been raised through borrowings. Overall, the Company's ability to generate internal funds has been maintained, although the persistently high inventory level warrants attention from a capital-efficiency perspective.

Quality of Earnings

Current-period Net Income was primarily generated by recurring business activities. Extraordinary items consisted only of extraordinary income of ¥0.01B, with extraordinary losses being negligible, indicating a low dependence on temporary factors. Of the ¥0.80B in non-operating income, equity-method investment income of ¥0.52B represented approximately 11.6% of Operating Income of ¥4.44B and was an important component supporting Ordinary Income. However, because it is affected by fluctuations in investee performance, the underlying recovery potential of Operating Income should be assessed separately. Foreign exchange gains of ¥0.11B were also market-driven and difficult to regard as a recurring source of earnings. Comprehensive Income was ¥3.24B, below Net Income of ¥3.73B, mainly due to foreign currency translation adjustments of △¥0.37B and adjustments related to retirement benefits of △¥0.09B. This divergence resulted from foreign-exchange valuation of overseas assets and should be distinguished from the Company's underlying earning power.

Earnings Forecast and Guidance

There has been no revision to the full-year earnings forecast of Revenue of ¥48.44B, Operating Income of ¥6.16B, and Ordinary Income of ¥6.60B. Progress for the cumulative Q3 period was 71.7% for Revenue, 72.1% for Operating Income, and 76.4% for Ordinary Income. Profit progress was broadly within the standard 75% range, although Operating Income was slightly below that level. To achieve the full-year plan, Q4 requires Revenue of ¥13.70B and Operating Income of ¥1.72B, levels broadly consistent with the cumulative Operating Margin of 12.8%.

Shareholder Returns

The full-year dividend forecast is ¥76.0 per share, comprising an assumed Q2 dividend of ¥35.0 and year-end dividend of ¥41.0, with no revision to the dividend forecast. Based on the full-year Net Income forecast of ¥4.79B and estimated total dividends of approximately ¥1.68B, the Payout Ratio is approximately 35.2%. Retained earnings of ¥33.66B, cash and deposits of ¥9.11B, and an Equity Ratio of 71.7% provide a financial foundation supportive of dividend sustainability. No disclosure has been made regarding share repurchases.

Risk Factors

1. Inventory efficiency risk: Inventories amount to ¥6.22B (finished goods: ¥6.22B, raw materials: ¥4.36B, work in process: ¥2.77B). If inventory turnover lengthens, the risk of valuation losses during periods of demand fluctuation will increase.

2. Accounts receivable collection risk: Accounts receivable and notes receivable total ¥8.05B. Together with electronic receivables of ¥5.41B, changes in collection terms and customer composition could affect working-capital efficiency.

3. Risk of fluctuations in the performance of equity-method investees: Equity-method investment income of ¥0.52B represents approximately 11.6% of Operating Income, meaning that the stability of Ordinary Income depends to a certain extent on the performance trends of investees.

Industry Benchmark (Reference; Compiled by the Company)

Profitability and Returns

The Company's Operating Margin and Net Profit Margin both exceed the industry median, indicating a superior level of profitability within the industry.

Growth and Capital Efficiency

The Revenue Growth Rate was slightly below the industry median, indicating relatively modest top-line growth momentum.

※Source: Compiled by the Company

Key Takeaways from the Results

1. Although the Operating Margin declined YoY, the gross margin of 40.6% and Net Profit Margin of 10.6% remained above the industry median, indicating that the underlying profitability base remains sound.

2. Financial soundness is high, as evidenced by the Equity Ratio of 71.7% and ample cash and current assets relative to current liabilities. Together with a Payout Ratio of 35.2%, this supports the stability of shareholder returns.

3. Improvement in Q4 Operating Income will be key to achieving the full-year plan. Revenue progress of 71.7% and Operating Income progress of 72.1% are slightly below the standard pace, while trends in working capital items such as inventories and accounts receivable will affect future profitability and funding efficiency.

Theoretical Share Price (Reference Value)

Sensitivity: ¥1,882–¥1,992 at Cost of Equity ±1%, and ¥1,932–¥1,942 at ω±0.1.

Notes:

• Net assets as of the quarter-end are used (there is a timing difference from the full-year forecast).
• Because net assets include non-controlling interests, the theoretical value may be calculated somewhat higher.

(Model used: Residual Income Model (Ohlson-type, explicit 5-year fade) / Interest rate reference month: 2026-07 / Mechanically calculated solely from publicly disclosed data; this is not a forecast of the market share price or a recommendation of any specific investment action, nor does it forecast or guarantee future share prices.)

---

This report is an earnings analysis document automatically generated by AI based on XBRL earnings release data. It does not recommend investment in any specific security. The industry benchmarks are reference information compiled by the Company based on publicly disclosed earnings data. Investment decisions should be made at your own responsibility, after consulting with professionals as necessary.

---End of Report---

---

AI Financial Analysis

Executive Summary

FY2026 Q3 results were resilient at the sales line but showed modest margin-led earnings pressure. Cumulative revenue increased 1.8% year on year to ¥34.74bn. Operating income declined 5.1% to ¥4.44bn, while ordinary income declined 3.5% to ¥5.05bn. Profit attributable to owners decreased 1.8% to ¥3.67bn, equivalent to EPS of ¥165.40. The gross margin declined by approximately 80bp year on year to 40.6% from 41.4%. The operating margin declined by approximately 90bp to 12.8% from 13.7%. The net margin eased by approximately 30bp to 10.6% from 10.9%. Gross profit was broadly flat at ¥14.12bn despite revenue growth, indicating that cost of sales rose faster than sales. SG&A expenses rose 2.5% to ¥9.67bn, exceeding the 1.8% sales increase and creating negative operating leverage. Non-operating income rose to ¥0.80bn from ¥0.63bn, supported by foreign-exchange gains of ¥0.11bn and equity-method earnings of ¥0.52bn. This non-operating contribution moderated the decline from operating income to ordinary income. Profit before tax of ¥5.06bn was close to ordinary income, and extraordinary gains were immaterial at ¥0.13bn. The effective tax rate was a normal 26.4%, producing a tax burden of 0.725. The annualized DuPont ROE of 12.5% remains within the good 10-15% range, supported by a high net margin and conservative balance-sheet leverage. Liquidity is exceptionally strong, with a 354.8% current ratio, ¥9.11bn of cash, and cash equal to 7.52 times short-term borrowings. The principal operational issue is working-capital intensity: the quality alerts identify receivable days of 63 days, inventory days of 177 days and 83 days under different inventory measures, and a 214-day cash conversion cycle. Full-year sales and operating-income progress are modestly below the standard 75% Q3 pace, whereas ordinary income and net income are slightly ahead, reflecting non-operating support. Management has not revised either its full-year earnings forecast or dividend plan, leaving the final quarter important for delivery of the operating-income target.

Profitability Analysis

Annualized ROE of 12.5% decomposes into a 10.6% net profit margin, 0.848x asset turnover, and 1.39x financial leverage. The strongest contributor is the net margin, which remains above the 10% excellent-profitability benchmark despite the year-on-year decline. Financial leverage is moderate rather than aggressive, so the ROE is principally earned through profitability and asset utilization rather than debt-funded balance-sheet expansion. The largest adverse change in the current period is operating profitability: the operating margin declined approximately 90bp to 12.8%. Gross-margin compression of approximately 80bp accounts for most of this deterioration, while SG&A growth of 2.5% exceeded sales growth of 1.8%. This indicates mild negative operating leverage and reduced conversion of incremental revenue into operating profit. The 5-factor decomposition remains favorable: the tax burden is 0.725 and interest burden is 1.139, the latter reflecting net non-operating financial and investment income in excess of interest expense. Interest expense was only ¥0.06bn against operating income of ¥4.44bn, supporting interest coverage of 69.21x. Equity-method earnings of ¥0.52bn, foreign-exchange gains of ¥0.11bn, interest income of ¥0.06bn, and dividend income of ¥0.03bn supported ordinary income. Because ordinary-income resilience partly reflects these non-operating items, sustained improvement in gross margin and SG&A discipline is more important than the current ordinary-income trend for evaluating underlying profitability. The company operates solely in the chemical-pump business, making consolidated margin performance directly representative of the core business.

Growth Assessment

Revenue growth of 1.8% to ¥34.74bn was positive but modest, while the 5.1% decline in operating income indicates that current growth is not yet translating into operating-profit expansion. Full-year guidance calls for revenue of ¥48.44bn, up 5.8% year on year, and operating income of ¥6.16bn, up 5.4%. Q3 cumulative revenue represents 71.7% of the full-year target, 3.3 percentage points below the standard 75% progress rate. Operating income progress is 72.1%, also 2.9 percentage points below the standard Q3 pace. Ordinary income progress is 76.4% against full-year guidance of ¥6.60bn, 1.4 percentage points ahead of the standard pace. Net income progress is 76.5% against the ¥4.79bn forecast, also slightly ahead of the standard pace. Achieving guidance therefore requires a stronger fourth-quarter sales and operating-income conversion than implied by the cumulative run rate. The absence of forecast revisions indicates management retains confidence in the plan, but the required acceleration should be assessed alongside gross-margin recovery. Construction in progress increased to ¥1.88bn from ¥0.90bn, indicating an active production-capacity or facility-investment pipeline. In chemical-pump manufacturing, demand can be affected by customers' capital-expenditure cycles, process-industry investment, and project timing; consequently, order timing and facility commissioning are relevant determinants of final-quarter performance.

Financial Health

Financial health is strong. Current assets of ¥36.89bn substantially exceed current liabilities of ¥10.40bn, resulting in a current ratio of 354.8% and working capital of ¥26.49bn. The quick ratio of 295.0% confirms that liquidity is not reliant on inventory monetization. Cash and deposits of ¥9.11bn exceed short-term loans of ¥1.21bn by 7.52 times. Interest-bearing debt totals ¥3.37bn, while total equity is ¥39.17bn and debt/capital is only 7.9%, demonstrating a conservatively capitalized balance sheet. The reported debt-to-equity ratio is 0.39x, and the debt/capital metric and strong interest coverage both indicate low debt-servicing risk. Current borrowings, including the current portion of long-term loans, are comfortably covered by current assets, so there is no evident short-term maturity mismatch. Long-term loans increased ¥1.30bn, or 151.5% year on year, to ¥2.16bn. This is the most notable change in the liability structure and likely relates to the expanded construction-in-progress balance and broader fixed-asset investment. Even after this increase, leverage remains modest and interest coverage is very strong. Goodwill of ¥1.87bn equals only 4.8% of equity and 3.4% of assets, limiting balance-sheet dependence on acquired-business value retention. Intangible assets represent 4.6% of total assets, also well below levels associated with elevated intangible-asset concentration. Asset retirement obligations of ¥0.23bn represent roughly 1.5% of total liabilities, indicating a manageable level of recognized environmental restoration obligations for a chemical-equipment manufacturer.

Notable B/S Changes

Long-term loans: +¥1.30bn (+151.5%) to ¥2.16bn - increased long-term funding remains modest relative to equity but should be monitored alongside capital-project execution. Construction in progress: +¥0.98bn (+109.2%) to ¥1.88bn - a substantial investment pipeline, representing approximately 20.0% of PPE and creating commissioning and return-on-investment risk. Property, plant and equipment: +¥0.73bn (+8.4%) to ¥9.39bn - indicates continuing manufacturing asset investment. Goodwill: -¥0.28bn (-13.0%) to ¥1.87bn - declining goodwill reduces acquired-asset exposure and potential impairment sensitivity. Finished goods: -¥1.11bn (-15.2%) to ¥6.22bn - favorable inventory reduction, although reported inventory-day alerts remain elevated. Investment securities: +¥0.39bn (+17.9%) to ¥2.55bn - greater exposure to market-value movements and investment-income variability.

Cash Flow Quality

The earnings profile contains limited extraordinary distortion. Profit before tax was ¥5.06bn, only marginally above ordinary income of ¥5.05bn, and extraordinary income was limited to ¥0.13bn. Gains on sales of investment securities and fixed assets were immaterial, while fixed-asset disposal and retirement losses were negligible. Accordingly, reported net income is primarily derived from recurring operating, financial, foreign-exchange, and equity-method income rather than large one-off gains. Working-capital efficiency nevertheless requires close monitoring. The quality alert for DSO of 63 days is above the 60-day warning threshold, indicating relatively slow cash collection for a manufacturing business. Trade receivables were broadly unchanged year on year at ¥8.05bn, while electronically recorded monetary claims increased to ¥5.41bn from ¥4.94bn; the combined receivable exposure remains material. The quality alert for DIO of 177 days indicates a potentially extended inventory holding period under one inventory definition. A separate DIO alert of 83 days is also above the 60-day manufacturing benchmark, so both reported inventory-efficiency measures warrant monitoring. The 214-day cash conversion cycle alert is substantially above the 120-day warning threshold and suggests that cash is tied up in the operating cycle for a prolonged period. Finished goods decreased 15.2% year on year to ¥6.22bn, which is a constructive directional development, although raw materials of ¥4.36bn and work in process of ¥2.77bn keep manufacturing inventory exposure meaningful. Construction in progress of ¥1.88bn equals approximately 20.0% of PPE and triggers the high-CIP alert; this reflects a significant investment pipeline but creates execution, commissioning, and return-on-investment risk if projects are delayed. No operating cash-flow, investing cash-flow, or capital-expenditure totals are provided in the reported figures, so cash conversion, free-cash-flow generation, and cash coverage of investment spending cannot be quantified.

Dividend Sustainability

The planned full-year dividend is ¥76.00 per share, with ¥35.00 per share already paid or declared at Q2, implying ¥41.00 per share for the year-end distribution. Based on forecast EPS of ¥215.82, the forecast dividend payout ratio is approximately 35.2%. This is comfortably below the 60% sustainability benchmark. The Q2 dividend of ¥35.00 per share represented approximately 21.2% of Q3 cumulative EPS of ¥165.40. The planned dividend is supported by substantial retained earnings of ¥336.59bn? No, retained earnings are ¥33.66bn, and by net cash liquidity relative to short-term debt. The company has ¥9.11bn of cash and only ¥3.37bn of interest-bearing debt, supporting financial flexibility for distributions while funding operations and construction projects. The balance-sheet increase in long-term debt and the elevated construction-in-progress balance suggest that capital-allocation discipline remains relevant. The forecast payout appears sustainable on earnings coverage, but free-cash-flow coverage cannot be quantified from the reported data. No dividend revision has been announced, consistent with management maintaining the ¥76.00 per-share plan.

Risk Assessment

Business risks include Margin risk: gross margin declined approximately 80bp and operating margin approximately 90bp year on year. In the single chemical-pump business, further input-cost pressure, pricing competition, or unfavorable sales mix would directly affect consolidated profitability., Demand and project-timing risk: full-year sales progress is 71.7% and operating-income progress is 72.1%, both below the standard 75% Q3 pace. Delivery timing and customer capital-investment cycles will be important to achieving the full-year operating plan., Working-capital risk: the 63-day DSO alert, 177-day and 83-day DIO alerts, and 214-day cash-conversion-cycle alert indicate a long operating cash cycle. This can constrain cash generation if receivables collection slows or inventory turns weaken., Manufacturing execution risk: construction in progress of ¥1.88bn, approximately 20.0% of PPE, creates risk around project completion, commissioning schedules, cost overruns, and realization of expected capacity or productivity benefits., Foreign-exchange and affiliate-income volatility: foreign-exchange gains of ¥0.11bn and equity-method earnings of ¥0.52bn supported ordinary income. These contributions can fluctuate independently of underlying chemical-pump operating performance..

Financial risks include Long-term loans increased 151.5% year on year to ¥2.16bn. Leverage remains low, but further debt-funded investment would raise financing and execution sensitivity., Comprehensive income of ¥3.24bn trailed net income of ¥3.67bn because other comprehensive income was negative ¥0.48bn, principally reflecting foreign-currency translation effects. This creates some equity-value sensitivity to currency movements., Goodwill is low at 4.8% of equity, limiting current impairment risk, but goodwill amortization and acquired-business performance remain relevant under JGAAP..

Key concerns include The highest-priority issue is restoration of operating-margin momentum, given revenue growth but declining operating income., The second priority is conversion of receivables and inventory into cash, given the long cash conversion cycle flagged by the quality alerts., The third priority is whether the elevated construction-in-progress balance converts into productive capacity and returns without further material debt expansion..

Investment Implications

Key takeaways include Annualized ROE of 12.5%, a 10.6% net margin, and a 12.8% operating margin indicate a fundamentally profitable business despite current margin compression., The balance sheet is highly liquid and conservatively leveraged, with a 354.8% current ratio, 7.9% debt/capital, and 69.21x interest coverage., Operating earnings lag ordinary and net-income progress because non-operating income, including equity-method earnings and FX gains, has cushioned the decline in operating income., The ¥76.00 forecast dividend implies a moderate approximately 35.2% payout ratio based on forecast EPS., Working-capital efficiency and capital-project execution are the key operational areas requiring attention..

Metrics to watch include Gross margin and operating margin recovery versus the current 40.6% and 12.8%, Q4 revenue and operating income needed to close the gap to ¥48.44bn and ¥6.16bn full-year guidance, Receivable days, inventory days, and cash conversion cycle relative to the 63-day, 177-day/83-day, and 214-day alerts, Construction-in-progress completion, capital deployment, and long-term-loan trends, Equity-method earnings and FX gains as contributors to ordinary income.

Regarding relative positioning, The company combines above-benchmark profitability and a strong net-cash-oriented liquidity profile with comparatively weak working-capital efficiency. Its 12.5% annualized ROE is good rather than exceptional, while the 12.8% operating margin remains solid for a manufacturer but has moved lower year on year. Low goodwill exposure and low debt/capital distinguish the balance sheet positively, whereas the extended cash conversion cycle and current operating-margin compression are the principal counterweights.